Markets:

Overview

News

Currencies

International

Treasuries

Zentalis Pharmaceuticals, Inc. - common stock (NQ:ZNTL)

1.335 -0.015 (-1.11%)

Streaming Delayed Price Updated: 11:08 AM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Zentalis Pharmaceuticals, Inc. - common stock

< Previous 1 2 3 4 Next >

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Reports Q3 2025 Earnings Beat Amidst Stock Decline ↗

November 10, 2025

Zentalis (ZNTL) beat Q3 2025 earnings estimates. The biotech firm has no revenue but a strong cash position, with key data for its lead drug, azenosertib, expected in late 2026.

Via Chartmill

Topics Earnings

Zentalis (ZNTL) Q2 Loss Narrows 70% ↗

August 06, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 26, 2025

Via Benzinga

Here are the top movers in Wednesday's session. ↗

February 05, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

(ZNTL) - Analyzing Zentalis Pharma's Short Interest ↗

June 21, 2024

Via Benzinga

Analyst Expectations for Zentalis Pharma's Future ↗

November 07, 2023

Via Benzinga

Where Zentalis Pharma Stands With Analysts ↗

August 10, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 05, 2025

Via Benzinga

These stocks that are showing activity before the opening bell on Wednesday. ↗

January 29, 2025

Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 29, 2025

Via Benzinga

FDA Removes Partial Hold On Zentalis Pharmaceuticals' Azenosertib Studies In Patients With Gynecological Cancers ↗

September 16, 2024

The FDA has lifted the partial clinical hold on Zentalis Pharmaceuticals' azenosertib studies. Zentalis plans to work with trial investigators to continue development while presenting additional data...

Via Benzinga

Newman Ferrara LLP Announces Corporate Governance Investigation of Zentalis Pharmaceuticals, Inc. – ZNTL

August 19, 2024

From Newman Ferrara LLP

Via Business Wire

Zentalis Pharmaceuticals, Inc. (ZNTL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

August 13, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

ZNTL Stock Earnings: Zentalis Pharma Misses EPS for Q2 2024 ↗

August 09, 2024

ZNTL stock results show that Zentalis Pharma missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

ZNTL Investors Have Opportunity to Join Zentalis Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm

August 01, 2024

From The Schall Law Firm

Via Business Wire

Wall Street's Top 10 Stock Calls This Week - Saturday, June 22 ↗

June 22, 2024

What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of June 17-21, 2024.

Via Talk Markets

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

June 20, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 19, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 19, 2024

Via Benzinga

Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

June 18, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 18, 2024

Via Benzinga

Why Is Small-Cap Cancer-Focused Zentalis Pharma Stock Trading Lower On Tuesday? ↗

June 18, 2024

Zentalis Pharmaceuticals announced the FDA's partial clinical hold on azenosertib studies due to recent patient deaths.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 18, 2024

Via Benzinga

ZNTL Stock Earnings: Zentalis Pharma Beats EPS, Beats Revenue for Q1 2024 ↗

May 07, 2024

ZNTL stock results show that Zentalis Pharma beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 28, 2024

Via Benzinga

MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential ↗

February 22, 2024

MAIA Biotechnology, a biotechnology company developing innovative cancer treatments, has seen its stock drift downwards for the past months.

Via Talk Markets

Immunome Exclusively Licenses Zentalis ROR1 Antibody-Drug Conjugate and Proprietary Technology Platform

January 08, 2024

From Immunome, Inc.

Via Business Wire

Morgan Stanley Maintains Overweight Rating for Zentalis Pharma: Here's What You Need To Know ↗

November 07, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 06, 2023

Via Benzinga

TreeHouse Foods, EchoStar, Hilton Grand Vacations, EchoStar And Other Big Stocks Moving Lower On Monday ↗

November 06, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 25 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.